Page Options
>> >>view
Akeso's market value surpasses 100 bln HKD for first time
2025-07-08

On July 4, shares of Zhongshan-based company Akeso rose for two consecutive days in the Hong Kong stock market, propelling its market value to exceed HK$100 billion for the first time.


As the world's sole pharmaceutical company with two novel tumor immunotherapy bispecific antibodies approved, Akeso has developed a robust pipeline of over 50 innovative drug candidates targeting major diseases including cancer, autoimmune disorders, inflammation, and metabolic diseases.

Close】 【Print
ICP Registration Number: 粤ICP备 11005604号
Police Registration Number: 44200002442868
Website ID: 4420000052
Sponsored by:  Office of Zhongshan Municipal People's Government
Technical Support:   Information Center of Zhongshan
Without written authorization from  Zhongshan Municipal People’s Government, the content of the site shall not be republished or used in any form.
About Us | Site Map| Privacy Statement| Contact us